Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of compound edaravone injection for acute ischemic stroke
CTR20211847Phase 2Active
- Sponsor
- Nanjing Youke Pharmaceutical
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone in ischemic stroke, brain infarction, sponsored by Nanjing Youke Pharmaceutical. Started Jul 2021; status: active.
02
Drugs
edaravone
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on CTR20211847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211847.